pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-5697 |
Genomic Coordinates | chr1: 9967381 - 9967458 |
Description | Homo sapiens miR-5697 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-5697 | |||||||||||||||
Sequence | 10| UCAAGUAGUUUCAUGAUAAAGG |31 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | Illumina | |||||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | NABP1 | ||||||||||||||||||||
Synonyms | OBFC2A, SOSS-B2, SSB2 | ||||||||||||||||||||
Description | nucleic acid binding protein 1 | ||||||||||||||||||||
Transcript | NM_001031716 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on NABP1 | |||||||||||||||||||||
3'UTR of NABP1 (miRNA target sites are highlighted) |
>NABP1|NM_001031716|3'UTR 1 CCTATGCTAAATACTCATGTGTAGTTTTTATACTACATGCCCTACTTGAACACTTATTGCACTTTTATTTATTGTTAACT 81 GTGAAAAGTACGTCCTTTATTGGGTTTCCTTTTATATTCTTGGTTTGTTAAGAAGAATGGTTTGTTTTTATAGCAAAACT 161 GTTAAGCTGCTCGAGTCTCCTGTTGAAGAATGGGAACACTGAAAAGTAGGGGCATTTATTTTTAGAGTAAAAAGATTATT 241 GGATAGCCTTTAAAAAACCTGCACCCATTTCATGGGTGAGTTACTTAAGACATCAGCTTTATAGCCTCTATGAGTCTATC 321 TTCTGTATAAGTTTTGTAATATTTAACATAAGGCTTAATGGGAGATGTTCTTTTGTCTTGTATTCAGATATTGCCAACTA 401 AAGCAATAACCATCAAAAAACACAAGAACTTGTCAATGCTAGCAGTAATTTTTGAGTGTTTGTGGCTCTCGGAATGATTG 481 ACTTCGTTCAGTGACTACTATTAAGATTTTCCAAGGACTGACTCATCCCAAATTTTTGTTGTATTACCAAAAAAACAGAT 561 TCCTTATCAGAATTTGGAATAGAATGTGATCTCTATTGCAACAAGTAATTTTAAAAGAAAGCTACATTTATTTTAGAGTA 641 GTGCTCCTAACATGTATTATCAACTTTGTGGATTACATTGGAGGAAAATTTAAAACTGGGGCCTTGAATATTTATTTTTT 721 GAAACTACCATGTTAAATACTGAAGTATAATTTGGGGGAGTTATAAAGTTATGATAAACATTCATCTGATTATTTTAAAC 801 AATAGTTGTGGTAGATAAACATACTGGAGGTGAGTCAAATTGAATTCATATAGTAACATGCAGTCTGAAGTCCTAGTTAC 881 TTAATAGGTACTCAGCCTGGAGTGAAAATCCTGGGTACTGACTTTGAGAGGAGTGAGTGTGCATGTTGTCAAAGTTTCTG 961 AACACAGTTCACATAGCCTTATTAGCAAAAGTTTTAAGAAATGGCTCTATCAAAGAAGCAATTGCAGCTTTATTCAGAAA 1041 TATAAAAGTGGAATTTATGTACATGTCATAAGTGGTACCCACTTCCCCTTTTTACTGTAGGGTGGATAACTCTTAGGATT 1121 TAACTCTTTGAATATTATCTCTTGAATAAAGCATGTGTTAATGTTAACAAACCTACGTAATTTTTGCCCTTTCAATGACT 1201 TACAGTGGAGAGCCAGTACATCTTAACTACTGTTGTAGTGATGGTATCAACCTCATGGTTACTTAGCTCTGCATTTGTTG 1281 CTTTGTTTTTTTTCCACTTCAAATCACAAAATAAGTAGATTTTGTTTTCTGAAAACTCCATAGCATTTGAATACAAAAAG 1361 TTGTGCCAGATTGTTTGCCCTAATTCACTGTGTTTAACAAATATTTCAGTACACACTATGTATTAGGCACTGTGTGGAAA 1441 GTGTTAAGGGGTAGACAAAATACCGAATAATCTCCACAAGTTTATTTGTGGTCTATAGTACTTTTGTAACTGGGGTTACA 1521 AAAATTATAGAAATTTTTTTCCTTTGTTCATATGCATATTCATGATTATAATTTGGCTTTGTTTGTGATTAATGTTTTCT 1601 TAAGATTTTCACATTATAGAATACCTCAAAAGAAGTTGTCTAAGGACTGGGATAGAGAGTATGTTTCATAAAATTGTAGA 1681 TGTTTAGAATTTTTAAAAACCCTACAAATTAGTATATGATTGTTTTATATAAGTAAGATAGGAGCAACACTTTAAATTAT 1761 TTGTGGGAGAATACAGCATTAAAGGTGATTTTAAAAGAAAAAAATTTGGAATTTTAGAAAATTTAAATGCTGTCAGGTAT 1841 GGAATGCTGGGCTTCCAATCCTGGCCTCATTGTCTCCTCACCTGTGATGTTGGATGAGTTATTACACTTGAAATGTCTTT 1921 AAGCCTTAGGTTCCACAAGTATGAAAACAAGTAAGTAACAGTATCCTTTCTAGACTTGTTTAAGATTTCCATGTAAGTAA 2001 TTATAATGACTTCTGACACATAATAATGTCGTCTTATACCCCAACAGTAGGAAAAAAATGCAGAATTCAGTATGAAAGTA 2081 TTGTTACCCTTTAACACAGTGGTCCCCAACCTTTTTGGCACCAGAGACCAGTCTCCTGGAAGACAGTTTTTCCGTGGGAT 2161 CGGGGGATGGTTTTGGGATGAAACTGTTCCACCTCAGGTCATCAGTCATTAGTTAGATTCTCATAAGGAGCGTGCAACCT 2241 CAATCCCTTGCATACTCATTTCACAATAGGGTTCATGCTCCTATGAGAATCTAATGCCACCACTCATCTGACAGGAGGTG 2321 GAGCTCAGGCAGTAAGTCTCCCTCGCCCGCCACTCACCTGCTGGGCGTTCCTGTTCCTAGCAGGCCAGAATTGATACTGA 2401 TCTAGGGGTTGGGGACCCCTGCTTAACATGTTGAGATTAAATGGAGAAAGACTTAAGCTTTTACTTTTGTGATTGACACT 2481 TGCTTCAATAATGTAACCTTGTTCTGTGTTTTTATCATTTATTAACAAATTTCTTTTTTCTTAAGGGAAGCCTCCAAAAT 2561 CAAAGAAAAGTGAGTTACAATCCATAATGAATATTTGCCTTACCAGCCTACTGGAACACATTCATCAAGAACTTAAGAGG 2641 AAGAAAGTTTTCTGCCTTCCTCCTTCCTAGTGCTCTCAGCTATCAACTTTGAAATAAGTTTAAACAACACCTACTGAAAA 2721 CAAAAACCACTTAGTATAAAAATATCCCCCACCAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 64859.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"HITS-CLIP data was present in GSM714642. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 64859.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065669. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM714642 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000410026.2 | 3UTR | CCCUACUUGAACACUUAUUGCACUUUUAUUUAUUGUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000410026.2 | 3UTR | CCCUACUUGAACACUUAUUGCACUUUUAUUUAUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000410026.2 | 3UTR | CCCUACUUGAACACUUAUUGCACUUUUAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000410026.2 | 3UTR | CCCUACUUGAACACUUAUUGCACUUUUAUUUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM1065669 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_8 |
Location of target site | ENST00000410026.2 | 3UTR | CCCUACUUGAACACUUAUUGCACUUUUAUUUAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
139 hsa-miR-5697 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT055801 | PLEKHA1 | pleckstrin homology domain containing A1 | 2 | 12 | ||||||||
MIRT066822 | ZDHHC18 | zinc finger DHHC-type containing 18 | 2 | 2 | ||||||||
MIRT067331 | SESN2 | sestrin 2 | 2 | 4 | ||||||||
MIRT072105 | CHAC1 | ChaC glutathione specific gamma-glutamylcyclotransferase 1 | 2 | 4 | ||||||||
MIRT080621 | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 2 | 8 | ||||||||
MIRT085213 | SLC5A3 | solute carrier family 5 member 3 | 2 | 4 | ||||||||
MIRT086450 | NABP1 | nucleic acid binding protein 1 | 2 | 6 | ||||||||
MIRT087916 | TNRC6B | trinucleotide repeat containing 6B | 2 | 4 | ||||||||
MIRT089461 | TET3 | tet methylcytosine dioxygenase 3 | 2 | 2 | ||||||||
MIRT089610 | MAT2A | methionine adenosyltransferase 2A | 2 | 10 | ||||||||
MIRT107597 | DNAJA1 | DnaJ heat shock protein family (Hsp40) member A1 | 2 | 6 | ||||||||
MIRT116036 | DEPDC1 | DEP domain containing 1 | 2 | 6 | ||||||||
MIRT147331 | KPNA2 | karyopherin subunit alpha 2 | 2 | 10 | ||||||||
MIRT206552 | RHOQ | ras homolog family member Q | 2 | 2 | ||||||||
MIRT211198 | FGF2 | fibroblast growth factor 2 | 2 | 6 | ||||||||
MIRT215297 | CREBRF | CREB3 regulatory factor | 2 | 2 | ||||||||
MIRT227712 | TBC1D13 | TBC1 domain family member 13 | 2 | 2 | ||||||||
MIRT243969 | MAP1B | microtubule associated protein 1B | 2 | 2 | ||||||||
MIRT250417 | TNRC6A | trinucleotide repeat containing 6A | 2 | 6 | ||||||||
MIRT294604 | ZNF460 | zinc finger protein 460 | 2 | 2 | ||||||||
MIRT300122 | STRADB | STE20-related kinase adaptor beta | 2 | 2 | ||||||||
MIRT354709 | SLC25A36 | solute carrier family 25 member 36 | 2 | 2 | ||||||||
MIRT442368 | ZC3HAV1L | zinc finger CCCH-type containing, antiviral 1 like | 2 | 2 | ||||||||
MIRT443617 | AVPR1A | arginine vasopressin receptor 1A | 2 | 2 | ||||||||
MIRT444711 | ZNF772 | zinc finger protein 772 | 2 | 2 | ||||||||
MIRT447556 | C14orf37 | chromosome 14 open reading frame 37 | 2 | 2 | ||||||||
MIRT448685 | MAPK6 | mitogen-activated protein kinase 6 | 2 | 2 | ||||||||
MIRT450817 | LIFR | LIF receptor alpha | 2 | 2 | ||||||||
MIRT451368 | UQCR11 | ubiquinol-cytochrome c reductase, complex III subunit XI | 2 | 2 | ||||||||
MIRT457302 | ZBTB45 | zinc finger and BTB domain containing 45 | 2 | 2 | ||||||||
MIRT458779 | CES2 | carboxylesterase 2 | 2 | 2 | ||||||||
MIRT458864 | CD55 | CD55 molecule (Cromer blood group) | 2 | 2 | ||||||||
MIRT460276 | SLC26A2 | solute carrier family 26 member 2 | 2 | 2 | ||||||||
MIRT461711 | ZNF426 | zinc finger protein 426 | 2 | 2 | ||||||||
MIRT466690 | TAF13 | TATA-box binding protein associated factor 13 | 2 | 4 | ||||||||
MIRT468811 | SACS | sacsin molecular chaperone | 2 | 10 | ||||||||
MIRT476013 | GTF2A1 | general transcription factor IIA subunit 1 | 2 | 8 | ||||||||
MIRT477764 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | 2 | 2 | ||||||||
MIRT478541 | CTNS | cystinosin, lysosomal cystine transporter | 2 | 2 | ||||||||
MIRT479230 | CKS2 | CDC28 protein kinase regulatory subunit 2 | 2 | 2 | ||||||||
MIRT479980 | CARD10 | caspase recruitment domain family member 10 | 2 | 2 | ||||||||
MIRT480800 | BLOC1S2 | biogenesis of lysosomal organelles complex 1 subunit 2 | 2 | 6 | ||||||||
MIRT482442 | ADM | adrenomedullin | 2 | 10 | ||||||||
MIRT487566 | LOXL2 | lysyl oxidase like 2 | 2 | 2 | ||||||||
MIRT499512 | RNF6 | ring finger protein 6 | 2 | 6 | ||||||||
MIRT501861 | MTDH | metadherin | 2 | 2 | ||||||||
MIRT502460 | FRAT2 | FRAT2, WNT signaling pathway regulator | 2 | 6 | ||||||||
MIRT502704 | CREBZF | CREB/ATF bZIP transcription factor | 2 | 6 | ||||||||
MIRT502856 | CHEK2 | checkpoint kinase 2 | 2 | 6 | ||||||||
MIRT503188 | ADAM17 | ADAM metallopeptidase domain 17 | 2 | 2 | ||||||||
MIRT503528 | ATG12 | autophagy related 12 | 2 | 2 | ||||||||
MIRT505087 | ZBTB18 | zinc finger and BTB domain containing 18 | 2 | 6 | ||||||||
MIRT507490 | E2F7 | E2F transcription factor 7 | 2 | 6 | ||||||||
MIRT518010 | RPL4 | ribosomal protein L4 | 2 | 4 | ||||||||
MIRT520767 | TCF23 | transcription factor 23 | 2 | 2 | ||||||||
MIRT524551 | CCND2 | cyclin D2 | 2 | 8 | ||||||||
MIRT527916 | B3GALT5 | beta-1,3-galactosyltransferase 5 | 2 | 2 | ||||||||
MIRT530025 | KIAA1875 | WD repeat domain 97 | 2 | 2 | ||||||||
MIRT532306 | HAUS3 | HAUS augmin like complex subunit 3 | 2 | 2 | ||||||||
MIRT532898 | ZNF451 | zinc finger protein 451 | 2 | 2 | ||||||||
MIRT533591 | TOB1 | transducer of ERBB2, 1 | 2 | 6 | ||||||||
MIRT534161 | SLC9A7 | solute carrier family 9 member A7 | 2 | 2 | ||||||||
MIRT539776 | KIAA0408 | KIAA0408 | 2 | 6 | ||||||||
MIRT541045 | SOGA3 | SOGA family member 3 | 2 | 6 | ||||||||
MIRT544310 | VANGL2 | VANGL planar cell polarity protein 2 | 2 | 4 | ||||||||
MIRT545812 | ZNF608 | zinc finger protein 608 | 2 | 2 | ||||||||
MIRT546436 | SNX5 | sorting nexin 5 | 2 | 2 | ||||||||
MIRT547715 | KLHL15 | kelch like family member 15 | 2 | 4 | ||||||||
MIRT549105 | C16orf70 | chromosome 16 open reading frame 70 | 2 | 4 | ||||||||
MIRT551192 | EPB41L3 | erythrocyte membrane protein band 4.1 like 3 | 2 | 2 | ||||||||
MIRT551671 | RPL9 | ribosomal protein L9 | 2 | 4 | ||||||||
MIRT552050 | ALG1 | ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase | 2 | 2 | ||||||||
MIRT553113 | UBR3 | ubiquitin protein ligase E3 component n-recognin 3 (putative) | 2 | 2 | ||||||||
MIRT553329 | TSC22D2 | TSC22 domain family member 2 | 2 | 2 | ||||||||
MIRT554371 | SFPQ | splicing factor proline and glutamine rich | 2 | 2 | ||||||||
MIRT555745 | PDCD10 | programmed cell death 10 | 2 | 2 | ||||||||
MIRT556351 | MAN2A1 | mannosidase alpha class 2A member 1 | 2 | 2 | ||||||||
MIRT557461 | GSK3B | glycogen synthase kinase 3 beta | 2 | 4 | ||||||||
MIRT558082 | EPC2 | enhancer of polycomb homolog 2 | 2 | 2 | ||||||||
MIRT558501 | CYP26B1 | cytochrome P450 family 26 subfamily B member 1 | 2 | 4 | ||||||||
MIRT560288 | HRH2 | histamine receptor H2 | 2 | 2 | ||||||||
MIRT561124 | ATP2B1 | ATPase plasma membrane Ca2+ transporting 1 | 2 | 2 | ||||||||
MIRT562629 | ARNTL2 | aryl hydrocarbon receptor nuclear translocator like 2 | 2 | 2 | ||||||||
MIRT564087 | NSA2 | NSA2, ribosome biogenesis homolog | 2 | 2 | ||||||||
MIRT564209 | SDE2 | SDE2 telomere maintenance homolog | 2 | 2 | ||||||||
MIRT564327 | CCNT1 | cyclin T1 | 2 | 2 | ||||||||
MIRT564996 | WNK1 | WNK lysine deficient protein kinase 1 | 2 | 2 | ||||||||
MIRT565212 | TROVE2 | TROVE domain family member 2 | 2 | 2 | ||||||||
MIRT568261 | BMP2K | BMP2 inducible kinase | 2 | 2 | ||||||||
MIRT571352 | RPL37 | ribosomal protein L37 | 2 | 4 | ||||||||
MIRT574715 | HAUS8 | HAUS augmin like complex subunit 8 | 2 | 2 | ||||||||
MIRT610600 | NUS1 | NUS1 dehydrodolichyl diphosphate synthase subunit | 2 | 2 | ||||||||
MIRT615444 | FAXC | failed axon connections homolog | 2 | 2 | ||||||||
MIRT618242 | PGBD4 | piggyBac transposable element derived 4 | 2 | 2 | ||||||||
MIRT618694 | CAMK1D | calcium/calmodulin dependent protein kinase ID | 2 | 2 | ||||||||
MIRT620289 | GLTP | glycolipid transfer protein | 2 | 2 | ||||||||
MIRT621242 | SIGLEC9 | sialic acid binding Ig like lectin 9 | 2 | 4 | ||||||||
MIRT626894 | ANGEL1 | angel homolog 1 | 2 | 2 | ||||||||
MIRT631347 | LATS1 | large tumor suppressor kinase 1 | 2 | 2 | ||||||||
MIRT631742 | NKX2-1 | NK2 homeobox 1 | 2 | 2 | ||||||||
MIRT633819 | WDR92 | WD repeat domain 92 | 2 | 2 | ||||||||
MIRT648370 | CYB5A | cytochrome b5 type A | 2 | 2 | ||||||||
MIRT648892 | TUBGCP5 | tubulin gamma complex associated protein 5 | 2 | 2 | ||||||||
MIRT653570 | SLC35B3 | solute carrier family 35 member B3 | 2 | 2 | ||||||||
MIRT654652 | PTAFR | platelet activating factor receptor | 2 | 2 | ||||||||
MIRT657173 | INTU | inturned planar cell polarity protein | 2 | 2 | ||||||||
MIRT658874 | DSTYK | dual serine/threonine and tyrosine protein kinase | 2 | 2 | ||||||||
MIRT666654 | RBM48 | RNA binding motif protein 48 | 2 | 2 | ||||||||
MIRT669273 | C1orf50 | chromosome 1 open reading frame 50 | 2 | 2 | ||||||||
MIRT671790 | RGS17 | regulator of G protein signaling 17 | 2 | 2 | ||||||||
MIRT673619 | HPSE | heparanase | 2 | 4 | ||||||||
MIRT676182 | HIST1H2BJ | histone cluster 1 H2B family member j | 2 | 2 | ||||||||
MIRT676317 | GTF2H2C | GTF2H2 family member C | 2 | 2 | ||||||||
MIRT676661 | LRRC27 | leucine rich repeat containing 27 | 2 | 2 | ||||||||
MIRT676678 | ICA1L | islet cell autoantigen 1 like | 2 | 2 | ||||||||
MIRT677497 | GTF2H2 | general transcription factor IIH subunit 2 | 2 | 2 | ||||||||
MIRT678021 | SPIC | Spi-C transcription factor | 2 | 2 | ||||||||
MIRT678030 | SLC1A5 | solute carrier family 1 member 5 | 2 | 2 | ||||||||
MIRT678363 | PPAP2B | phospholipid phosphatase 3 | 2 | 2 | ||||||||
MIRT678438 | PDE4C | phosphodiesterase 4C | 2 | 2 | ||||||||
MIRT678497 | ARHGEF39 | Rho guanine nucleotide exchange factor 39 | 2 | 2 | ||||||||
MIRT678648 | PDCD4 | programmed cell death 4 | 2 | 2 | ||||||||
MIRT679089 | PURB | purine rich element binding protein B | 2 | 2 | ||||||||
MIRT679121 | NMNAT1 | nicotinamide nucleotide adenylyltransferase 1 | 2 | 2 | ||||||||
MIRT680087 | THAP1 | THAP domain containing 1 | 2 | 2 | ||||||||
MIRT684600 | ORAI2 | ORAI calcium release-activated calcium modulator 2 | 2 | 2 | ||||||||
MIRT686267 | YTHDF1 | YTH N6-methyladenosine RNA binding protein 1 | 2 | 2 | ||||||||
MIRT687836 | ISG20L2 | interferon stimulated exonuclease gene 20 like 2 | 2 | 2 | ||||||||
MIRT688028 | GPN2 | GPN-loop GTPase 2 | 2 | 2 | ||||||||
MIRT697864 | UBE2H | ubiquitin conjugating enzyme E2 H | 2 | 2 | ||||||||
MIRT698304 | TMEM2 | transmembrane protein 2 | 2 | 2 | ||||||||
MIRT701714 | MTMR12 | myotubularin related protein 12 | 2 | 2 | ||||||||
MIRT703736 | FAM126B | family with sequence similarity 126 member B | 2 | 2 | ||||||||
MIRT705971 | ACBD5 | acyl-CoA binding domain containing 5 | 2 | 2 | ||||||||
MIRT714346 | DIP2A | disco interacting protein 2 homolog A | 2 | 2 | ||||||||
MIRT714614 | EXO5 | exonuclease 5 | 2 | 2 | ||||||||
MIRT722607 | CCDC152 | coiled-coil domain containing 152 | 2 | 2 | ||||||||
MIRT722876 | XPNPEP3 | X-prolyl aminopeptidase 3 | 2 | 2 | ||||||||
MIRT724406 | WWC1 | WW and C2 domain containing 1 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|